Susan H. Eshleman - Concepedia

Author

Susan H. Eshleman

Also Known As

Chen, Ying Q, Chen, Ying Q., Christophe Fraser, Cohen, Myron S, Eshleman, Susan H., Fields, Sheldon D., Fogel, Jessica M, Gallant, Joel, Grinsztejn, Beatriz, Jabara, Cassandra B.

290

Publications

20.7K

Citations

H-Index

128

Concepts

All Affiliations

Johns Hopkins University Johns Hopkins Medicine Fred Hutch Cancer Center National Institutes of Health National Institute of Allergy and Infectious Diseases

About

Susan H. Eshleman is an author at Johns Hopkins University specializing in medicine, hiv, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	50	3.7K
2	Nursing	3	3	288
3	Engineering	2	2	144
4	Natural Sciences	2	2	146
5	Health Sciences	1	1	46

Susan H. Eshleman

182

Publications

19.9K

Citations

H-Index

Page 1

	Year	Citations
Prevention of HIV-1 Infection with Early Antiretroviral Therapy Myron S. Cohen, Ying Qing Chen, Marybeth McCauley, New England Journal of Medicine	2011	6.9K
Antiretroviral Therapy for the Prevention of HIV-1 Transmission Myron S. Cohen, Ying Qing Chen, Marybeth McCauley, New England Journal of Medicine	2016	1.7K
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women Raphael J. Landovitz, Deborah Donnell, Meredith E. Clement, New England Journal of Medicine	2021	773
Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial Beatriz Grinsztejn, Mina C. Hosseinipour, Heather J. Ribaudo, The Lancet Infectious Diseases Hptn 052Hiv/aids CounsellingTreatment And PreventionHuman RetrovirusAntiviral Therapy	2014	507
Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial Sinéad Delany‐Moretlwe, James P. Hughes, Peter Bock, The Lancet Sexual HealthPhase 3Treatment And PreventionHuman RetrovirusAntiviral Therapy	2022	498
Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012) Susan H. Eshleman, Martin Mracna, Laura Guay, AIDS	2001	420
Effect of Universal Testing and Treatment on HIV Incidence — HPTN 071 (PopART) Richard Hayes, Deborah Donnell, Sian Floyd, New England Journal of Medicine	2019	329
The effect of a conditional cash transfer on HIV incidence in young women in rural South Africa (HPTN 068): a phase 3, randomised controlled trial Audrey Pettifor, Catherine MacPhail, James P. Hughes, The Lancet Global Health	2016	257
Antiretroviral Treatment for Children with Peripartum Nevirapine Exposure Paul Palumbo, Jane C. Lindsey, Michael D. Hughes, New England Journal of Medicine	2010	218
Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission J. Brooks Jackson, Graziella Becker‐Pergola, Laura Guay, AIDS	2000	212

Page 1